Colorectal cancer (CRC), one of the most common malignant diseases, ranks second in
morbidity and third in mortality among all cancers worldwide 1. The liver is the most common …

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and
women.[1] Over one-half of newly diagnosed individuals will develop liver metastases …

The management of metastatic colon and rectal cancer has undergone significant evolution
over the last few decades. Due to advancements in chemotherapy, surgical techniques, and …

Efforts to combat colorectal cancer have benefited from improved screening and
surveillance, which facilitates early detection. The survival rate associated with diagnosis at …

(1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer
worldwide. Its first main metastatic diffusion spreads to the liver. Different mechanisms such …

Ideally, tumors that might cause morbidity and mortality should be treated, preferably early,
with proven, convincing, and effective therapy to prevent tumor progression or recurrence …

BACKGROUND Approximately 30% of patients with colorectal cancer (CRC) will develop
liver metastases (CRLM) over the course of their disease. Half of CRLM arise as …

The current management of colorectal cancer liver metastasis (CRCLM) patients involves a
multidisciplinary approach, with surgical resection remaining the primary curative option …

Colorectal cancer is the second leading cause of cancer-related deaths in the United States
and accounts for an estimated 1 million deaths annually worldwide. The liver is the most …

Liver metastases are the most common site of metastatic spread in colorectal cancer.
Current treatment approaches involve effective systemic therapies in combination with …